Learn how SOPHiA GENETICS can support you in overcoming the limitations and maximizing the ability to detect Homologous Recombination Repair (HRR) deficiency in somatic samples. Following an introduction on the growing importance of broadening HRR deficiency detection beyond BRCA by Mikhail Pertziger our Oncology Product Manager, Christian Pozzorini, our Director of Biostatistics Research will present how our HRS solution evolved to include CNV screening in its variant detection capabilities.
Mikhail Pertziger, PhD
Product Manager – SOPHiA GENETICS
Christian Pozzorini, PhD
Director of Biostatistics Research – SOPHiA GENETICS
Registration is full. If you have already registered, please log in or use the link from your registration confirmation email.